Andreessen Horowitz has secured $7.6 billion in commitments for four new funds, marking the venture firm’s largest fundraising round to date. The capital will be deployed across artificial intelligence, crypto and biotech startups, according to a Reuters report.

The new funds underscore continued investor appetite for sectors that have drawn intense attention from venture capital firms, particularly AI, where demand has surged alongside rapid advances in generative tools and enterprise adoption. Crypto remains a more volatile bet, but a16z has stayed active in the space through market swings.

Biotech is also part of the firm’s expanded push, reflecting broader interest in companies developing next-generation treatments, diagnostics and life sciences infrastructure. The fundraising gives a16z fresh firepower as competition for promising startups remains high.

The size of the raise highlights how some of the largest technology investors continue to secure major pools of capital even as the startup market adjusts to tighter financing conditions and higher expectations for returns.